---
input_text: 'Sickle Cell Disease and CKD: An Update.BACKGROUND: Sickle cell disease
  is an inherited red blood cell disorder that affects approximately 100,000 people
  in the U.S. and 25 million people worldwide. Vaso-occlusion and chronic hemolysis
  lead to dysfunction to vital organ systems, with the kidneys being among the most
  commonly affected organs. SUMMARY: Early renal manifestations include medullary
  ischemia with loss of urine concentrating ability and hyperfiltration. This can
  be followed by progressive damage characterized by persistent albuminuria and a
  decline in the estimated glomerular filtration rate. The risk of sickle nephropathy
  is greater in those with the APOL1 G1 and G2 kidney risk variants and variants in
  HMOX1 and lower in those that co-inherit alpha-thalassemia. Therapies to treat sickle
  cell disease-related kidney damage focus on sickle cell disease modifying therapies
  (e.g. hydroxyurea) or those adopted from the non-sickle cell disease kidney literature
  (e.g. renin-angiotensin-aldosterone system inhibitors), although data on their clinical
  efficacy are limited to small studies with short follow up periods. Kidney transplantation
  for end-stage kidney disease improves survival compared to hemodialysis but is underutilized
  in this patient population. KEY MESSAGES: Kidney disease is a major contributor
  to early mortality and more research is needed to understand the pathophysiology
  and to develop targeted therapies to improve kidney health in sickle cell disease.'
raw_completion_output: |-
  primary_disease: Sickle Cell Disease

  medical_actions: Sickle cell disease modifying therapies; Hydroxyurea; Renin-angiotensin-aldosterone system inhibitors; Kidney transplantation

  symptoms: Medullary ischemia; Loss of urine concentrating ability; Hyperfiltration; Persistent albuminuria; Decline in the estimated glomerular filtration rate

  chemicals: Hydroxyurea

  action_annotation_relationships: Sickle cell disease modifying therapies TREATS Medullary ischemia IN Sickle Cell Disease; Sickle cell disease modifying therapies TREATS Loss of urine concentrating ability IN Sickle Cell Disease; Sickle cell disease modifying therapies TREATS Hyperfiltration IN Sickle Cell Disease; Sickle cell disease modifying therapies TREATS Persistent albuminuria IN Sickle Cell Disease; Sickle cell disease modifying therapies TREATS Decline in the estimated glomerular filtration rate IN Sickle Cell Disease; Hydroxyurea TREATS Medullary ischemia IN Sickle Cell Disease; Hydroxyurea TREATS Loss of urine concentrating ability IN Sickle Cell Disease; Hydroxyurea TREATS Hyperfiltration IN Sickle Cell Disease; Hydroxyurea TREATS Persistent albuminuria IN Sickle Cell Disease; Hydroxyurea TREATS Decline in the estimated glomerular filtration rate IN Sickle Cell Disease; Renin-angiotensin-aldosterone system inhibitors TREATS Medullary ischemia IN Sickle Cell Disease; Renin-angiotensin-aldosterone system inhibitors TREATS Loss of urine concentrating ability IN Sickle Cell Disease; Renin-angiotensin-aldosterone system inhibitors TREATS Hyperfiltration IN Sickle Cell Disease; Renin-angiotensin-aldosterone system inhibitors TREATS Persistent albuminuria IN Sickle Cell Disease; Renin-angiotensin-aldosterone system inhibitors TREATS Decline in the estimated glomerular filtration rate IN Sickle Cell Disease; Kidney transplantation TREATS Persistent albuminuria IN Sickle Cell Disease; Kidney transplantation TREATS Decline in the estimated glomerular filtration rate IN Sickle Cell Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Kidney transplantation TREATS Decline in the estimated glomerular filtration rate IN Sickle Cell Disease

  ===

extracted_object:
  primary_disease: MONDO:0011382
  medical_actions:
    - Sickle cell disease modifying therapies
    - Hydroxyurea
    - Renin-angiotensin-aldosterone system inhibitors
    - Kidney transplantation
  symptoms:
    - Medullary ischemia
    - Loss of urine concentrating ability
    - Hyperfiltration
    - Persistent albuminuria
    - Decline in the estimated glomerular filtration rate
  chemicals:
    - CHEBI:44423
  action_annotation_relationships:
    - subject: Sickle cell disease modifying therapies
      predicate: TREATS
      object: Medullary ischemia
      qualifier: MONDO:0011382
    - subject: <Sickle cell disease modifying therapies>
      predicate: <TREATS>
      object: <Loss of urine concentrating ability>
      qualifier: <Sickle Cell Disease>
      subject_extension: <Sickle cell disease modifying therapies>
    - subject: <Sickle cell disease modifying therapies>
      predicate: <TREATS>
      object: <Hyperfiltration>
      qualifier: <Sickle Cell Disease>
      subject_extension: <Sickle cell disease modifying therapies>
    - subject: <Sickle cell disease modifying therapies>
      predicate: <TREATS>
      object: <Persistent albuminuria>
      qualifier: <Sickle Cell Disease>
      subject_extension: <Sickle cell disease modifying therapies>
    - subject: Sickle cell disease modifying therapies
      predicate: TREATS
      object: Decline in the estimated glomerular filtration rate
      qualifier: MONDO:0011382
      subject_extension: Sickle cell disease modifying therapies
    - predicate: TREATS
      object: Medullary ischemia
      qualifier: MONDO:0011382
      subject_extension: CHEBI:44423
    - subject: Hydroxyurea
      predicate: TREATS
      object: Loss of urine concentrating ability
      qualifier: MONDO:0011382
      subject_extension: CHEBI:44423
    - predicate: TREATS
      object: Hyperfiltration
      qualifier: MONDO:0011382
      subject_extension: CHEBI:44423
    - predicate: TREATS
      object: Persistent albuminuria
      qualifier: MONDO:0011382
      subject_extension: CHEBI:44423
    - subject: Hydroxyurea
      predicate: TREATS
      object: Decline in the estimated glomerular filtration rate
      qualifier: MONDO:0011382
      subject_extension: CHEBI:44423
    - subject: Renin-angiotensin-aldosterone system inhibitors
      predicate: TREATS
      object: Medullary ischemia
      qualifier: MONDO:0011382
      subject_extension: Renin-angiotensin-aldosterone system inhibitors
    - subject: Renin-angiotensin-aldosterone system inhibitors
      predicate: TREATS
      object: Loss of urine concentrating ability
      qualifier: MONDO:0011382
      subject_extension: Renin-angiotensin-aldosterone system inhibitors
    - subject: Renin-angiotensin-aldosterone system inhibitors
      predicate: TREATS
      object: Hyperfiltration
      qualifier: MONDO:0011382
      subject_extension: Renin-angiotensin-aldosterone system inhibitors
    - subject: Renin-angiotensin-aldosterone system inhibitors
      predicate: TREATS
      object: Persistent albuminuria
      qualifier: MONDO:0011382
      subject_extension: Renin-angiotensin-aldosterone system inhibitors
    - subject: Renin-angiotensin-aldosterone system inhibitors
      predicate: TREATS
      object: Decline in the estimated glomerular filtration rate
      qualifier: MONDO:0011382
      subject_extension: Renin-angiotensin-aldosterone system inhibitors
    - subject: Kidney transplantation
      predicate: TREATS
      object: Persistent albuminuria
      qualifier: MONDO:0011382
    - subject: Kidney transplantation
      predicate: TREATS
      object: Decline in the estimated glomerular filtration rate
      qualifier: MONDO:0011382
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0100096
    label: SARS-CoV-2
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Intrauterine growth restriction
  - id: CHEBI:44423
    label: Hydroxyurea (HU)
  - id: CHEBI:35143
    label: Haemoglobin (Hb)
  - id: HP:0001622
    label: Preterm delivery
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0032654
    label: Endothelial dysfunction
  - id: HP:0012418
    label: Hypoxia
  - id: HP:0001409
    label: Portal hypertension
  - id: MAXO:0001001
    label: Gene therapies
  - id: MAXO:0000756
    label: Transfusion
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0009047
    label: Total hip replacement (THR)
  - id: CHEBI:22720
    label: Benzodiazepines
  - id: MONDO:0006079
    label: Acute chest syndrome (ACS)
  - id: CHEBI:24859
    label: Iodine
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:17334
    label: penicillin
  - id: MAXO:0000118
    label: immunizations
  - id: HP:0001903
    label: anemia
  - id: HP:0001297
    label: stroke
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: HP:0001518
    label: Low birth weight
  - id: MAXO:0001006
    label: Full blood count
  - id: MAXO:0000825
    label: Reticulocyte count
  - id: MAXO:0000427
    label: Brain magnetic resonance imaging (MRI)
  - id: HP:0012592
    label: albuminuria
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: HP:0010783
    label: Redness
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: CHEBI:114786
    label: sodium metabisulfite
  - id: CHEBI:15365
    label: aspirin
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0012622
    label: CKD
  - id: MAXO:0000969
    label: optical coherence tomography (OCT)
  - id: HP:0000505
    label: visual impairment
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:82557
    label: treosulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: HP:0100603
    label: Hypertensive disorder of pregnancy (HDP)
  - id: CHEBI:26308
    label: unweighted polygenic risk score (PRS)
  - id: CHEBI:35480
    label: Analgesics
  - id: HP:0012213
    label: Decreased glomerular filtration rate
  - id: HP:0012398
    label: Peripheral oedema
  - id: HP:0001685
    label: Cardiac fibrosis
  - id: MONDO:0005570
    label: hematologic diseases
  - id: HP:0001871
    label: hematologic diseases
  - id: HP:0001712
    label: Left ventricular hypertrophy
  - id: HP:0007760
    label: SCD
  - id: MAXO:0000149
    label: Hematopoietic cell transplant (HCT)
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0012531
    label: Pain
  - id: CHEBI:51371
    label: muscle relaxants
  - id: HP:0002140
    label: Arterial ischemic stroke
  - id: MONDO:0019402
    label: Thalassemia major
  - id: MAXO:0000536
    label: Chorionic villus sampling (CVS)
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: MONDO:0005161
    label: Human papillomavirus (HPV) infection
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000447
    label: Surgical removal
  - id: HP:0033138
    label: Right atrial thrombus
  - id: HP:0000989
    label: pruritus
  - id: MAXO:0010041
    label: skin grafting
  - id: MAXO:0000058
    label: Pharmacotherapies
  - id: HP:0001513
    label: obesity
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: HP:0002617
    label: vasculopathy
  - id: MAXO:0000068
    label: Transplantation
  - id: HP:0004870
    label: chronic hemolytic anemia
  - id: CHEBI:27690
    label: acetazolamide
  - id: CHEBI:22984
    label: Calcium
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: CHEBI:18050
    label: L-glutamine
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0000952
    label: jaundice
  - id: HP:0025637
    label: vasospasm
  - id: CHEBI:125354
    label: plerixafor
